A Candidate Dual Active Galactic Nucleus At Z=1.175

The X-ray source CXOXBJ142607.6+353351 (CXOJ1426+35), which was identified in a 172 ks Chandra image in the Bootes field, shows double-peaked rest-frame optical/UV emission lines, separated by 0.''69 (5.5 kpc) in the spatial dimension and by 690 km s(-1) in the velocity dimension. The high excitation lines and emission line ratios indicate both systems are ionized by an active galactic nucleus (AGN) continuum, and the double-peaked profile resembles that of candidate dual AGNs. At a redshift of z = 1.175, this source is the highest redshift candidate dual AGN yet identified. However, many sources have similar emission line profiles for which other interpretations are favored. We have analyzed the substantial archival data available in this field as well as acquired near-infrared (NIR) adaptive optics (AO) imaging and NIR slit spectroscopy. The X-ray spectrum is hard, implying a column density of several 10(23) cm(-2). Though heavily obscured, the source is also one of the brightest in the field, with an absorption-corrected 2-10 keV luminosity of similar to 10(45) erg s(-1). Outflows driven by an accretion disk may produce the double-peaked lines if the central engine accretes near the Eddington limit. However, we may be seeing the narrow line regions of two AGNs following a galactic merger. While the AO image reveals only a single source, a second AGN would easily be obscured by the significant extinction inferred from the X-ray data. Understanding the physical processes producing the complex emission line profiles seen in CXOJ1426+35 and related sources is important for interpreting the growing population of dual AGN candidates.National Science Foundation AST-0708490Strategic University Research Partnership ProgramNational Aeronautics and Space AdministrationW. M. Keck FoundationSmithsonian Astrophysical Observatory SV4-74018, A31Astronom

Mid-infrared Selection of Active Galactic Nuclei with the Wide-Field Infrared Survey Explorer. I. Characterizing WISE-selected Active Galactic Nuclei in COSMOS

The Wide-field Infrared Survey Explorer (WISE) is an extremely capable and efficient black hole finder. We present a simple mid-infrared color criterion, W1 – W2 ≥ 0.8 (i.e., [3.4]–[4.6] ≥0.8, Vega), which identifies 61.9 ± 5.4 active galactic nucleus (AGN) candidates per deg^2 to a depth of W2 ~ 15.0. This implies a much larger census of luminous AGNs than found by typical wide-area surveys, attributable to the fact that mid-infrared selection identifies both unobscured (type 1) and obscured (type 2) AGNs. Optical and soft X-ray surveys alone are highly biased toward only unobscured AGNs, while this simple WISE selection likely identifies even heavily obscured, Compton-thick AGNs. Using deep, public data in the COSMOS field, we explore the properties of WISE-selected AGN candidates. At the mid-infrared depth considered, 160 μJy at 4.6 μm, this simple criterion identifies 78% of Spitzer mid-infrared AGN candidates according to the criteria of Stern et al. and the reliability is 95%. We explore the demographics, multiwavelength properties and redshift distribution of WISE-selected AGN candidates in the COSMOS field

Controlling Chaos through Compactification in Cosmological Models with a Collapsing Phase

We consider the effect of compactification of extra dimensions on the onset of classical chaotic "Mixmaster" behavior during cosmic contraction. Assuming a universe that is well-approximated as a four-dimensional Friedmann-Robertson--Walker model (with negligible Kaluza-Klein excitations) when the contraction phase begins, we identify compactifications that allow a smooth contraction and delay the onset of chaos until arbitrarily close the big crunch. These compactifications are defined by the de Rham cohomology (Betti numbers) and Killing vectors of the compactification manifold. We find compactifications that control chaos in vacuum Einstein gravity, as well as in string theories with N = 1 supersymmetry and M-theory. In models where chaos is controlled in this way, the universe can remain homogeneous and flat until it enters the quantum gravity regime. At this point, the classical equations leading to chaotic behavior can no longer be trusted, and quantum effects may allow a smooth approach to the big crunch and transition into a subsequent expanding phase. Our results may be useful for constructing cosmological models with contracting phases, such as the ekpyrotic/cyclic and pre-big bang models.Comment: 1 figure. v2/v3: minor typos correcte

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

BackgroundYKL-40, also known as chitinase-3-like protein 1 (CHI3L1), is a secreted glycoprotein produced by various cell types including stromal, immune, and cancer cells. It contributes to cancer progression through tumor-promoting inflammation and has been shown to inhibit the cytotoxicity of T and NK lymphocytes. In vivo studies have demonstrated synergistic anti-cancer effects of blocking YKL-40 in combination with immune checkpoint inhibitors (ICIs). Biomarkers for the prediction of the response to ICIs are highly needed. We investigated the association between plasma YKL-40 and clinical benefit and survival in patients with metastatic pancreatic cancer (mPC) receiving ICIs and stereotactic body radiotherapy (SBRT).MethodsBlood samples were collected from 84 patients with mPC who participated in the randomized phase II CheckPAC study, in which patients received nivolumab with or without ipilimumab combined with a single fraction of SBRT. Plasma YKL-40 was measured using a commercial ELISA kit.ResultsElevated baseline plasma YKL-40 was an independent predictor of shorter overall survival (OS) (HR 2.19, 95% CI 1.21–3.95). A ≥ 40% decrease in plasma YKL-40 during treatment was associated with longer progression-free survival (p = 0.009) and OS (p = 0.0028). There was no correlation between plasma YKL-40 and the tumor burden marker CA19-9 at baseline or during treatment.ConclusionThis study contributes new knowledge regarding YKL-40 as a predictor of clinical benefit from ICIs and radiotherapy. These exploratory results warrant further investigation of YKL-40 as a biomarker for patients treated with immunotherapies.Clinical trial registrationClinicaltrials.gov, identifier NCT02866383

Early laboratory diagnosis of COVID-19 by antigen detection in blood samples of the SARS-COV-2 nucleocapsid protein

The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection and from 505 outpatients predominantly with relevant symptoms of COVID-19 simultaneously with PCR testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confirmed infection, the diagnostic sensitivity of the ELISA was 91.6%. The mean NP concentration of the 131 ELISA-positive blood samples was 1,734 pg/ml (range, 10 to 3,840 pg/ml). An exponential decline in NP concentration was observed for 368 blood samples collected over the first 4 weeks after PCR-confirmed SARS-CoV-2 infection, and all blood samples taken later had an NP concentration below the 10-pg/ml diagnostic cutoff. The diagnostic sensitivity of the ELISA was 81.4% for the 43 blood samples collected from outpatients with a simultaneous positive PCR test, and the mean NP concentration of the 35 ELISA-positive samples was 157 pg/ml (range, 10 to 1,377 pg/ml). For the 462 outpatients with a simultaneous negative PCR test, the diagnostic specificity of the ELISA was 99.8%. In conclusion, the SARS-CoV-2 NP ELISA is a suitable laboratory diagnostic test for COVID-19, particularly for hospitals, where blood samples are readily available and screening of serum or plasma by ELISA can facilitate prevention of nosocomial infections and reduce the requirement for laborious swab sampling and subsequent PCR analysis to confirmatory tests only

WISE Discovery of Low Metallicity Blue Compact Dwarf Galaxies

We report two new low metallicity blue compact dwarf galaxies (BCDs), WISEP J080103.93+264053.9 (hereafter W0801+26) and WISEP J170233.53+180306.4 (hereafter W1702+18), discovered using the Wide-field Infrared Survey Explorer (WISE). We identified these two BCDs from their extremely red colors at mid-infrared wavelengths, and obtained follow-up optical spectroscopy using the Low Resolution Imaging Spectrometer on Keck I. The mid-infrared properties of these two sources are similar to the well studied, extremely low metallicity galaxy SBS 0335-052E. We determine metallicities of 12 + log(O/H) = 7.75 and 7.63 for W0801+26 and W1702+18, respectively, placing them amongst a very small group of very metal deficient galaxies (Z 300 Angstrom Hbeta equivalent widths, similar to SBS 0335-052E, imply the existence of young (< 5 Myr) star forming regions. We measure star formation rates of 2.6 and 10.9 Msun/yr for W0801+26 and W1702+18, respectively. These BCDs, showing recent star formation activity in extremely low metallicity environments, provide new laboratories for studying star formation in extreme conditions and are low-redshift analogs of the first generation of galaxies to form in the universe. Using the all-sky WISE survey, we discuss a new method to identify similar star forming, low metallicity BCDs.Comment: Accepted for publication in ApJ

Magnetic correlations in the triangular antiferromagnet FeGa2 S4

The crystal structure and magnetic correlations in triangular antiferromagnet FeGa2S4 are studied by x-ray diffraction, magnetic susceptibility, neutron diffraction, and neutron inelastic scattering. We report significant mixing at the cation sites and disentangle magnetic properties dominated by major and minor magnetic sites. The magnetic short-range correlations at 0.77Å-1 correspond to the major sites and being static at base temperature they evolve into dynamic correlations around 30-50 K. The minor sites contribute to the magnetic peak at 0.6Å-1, which vanishes at 5.5 K. Our analytical studies of triangular lattice models with bilinear and biquadratic terms provide the ratios between exchanges for the proposed ordering vectors. The modeling of the inelastic neutron spectrum within linear spin-wave theory results in the set of exchange couplings J1=1.7,J2=0.9,J3=0.8meV for the bilinear Heisenberg Hamiltonian. However, not all features of the excitation spectrum are explained with this model.Fil: Guratinder, K.. Universidad de Ginebra; SuizaFil: Schmidt, M.. Max-Planck-Institut für Chemische Physik fester Stoffe; AlemaniaFil: Walker, H. C.. Rutherford Appleton Laboratory; Reino UnidoFil: Bewley, R.. Rutherford Appleton Laboratory; Reino UnidoFil: Wörle, M.. Laboratorium für Anorganische Chemie; SuizaFil: Cabra, Daniel Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Física de Líquidos y Sistemas Biológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Física de Líquidos y Sistemas Biológicos; ArgentinaFil: Osorio, Santiago Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Unidad Ejecutora Instituto de Nanociencia y Nanotecnología. Unidad Ejecutora Instituto de Nanociencia y Nanotecnología - Nodo Bariloche | Comisión Nacional de Energía Atómica. Unidad Ejecutora Instituto de Nanociencia y Nanotecnología. Unidad Ejecutora Instituto de Nanociencia y Nanotecnología - Nodo Bariloche; ArgentinaFil: Villalba, Maria Luisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Física de Líquidos y Sistemas Biológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Física de Líquidos y Sistemas Biológicos; ArgentinaFil: Madsen, A. K.. Paul Scherrer Institute; SuizaFil: Keller, L.. Paul Scherrer Institute; SuizaFil: Wildes, A.. Institut Laue Langevin; FranciaFil: Puphal, P.. Institut Laue Langevin; FranciaFil: Cervellino, A.. Institut Laue Langevin; FranciaFil: Rüegg, Ch.. Universidad de Ginebra; SuizaFil: Zaharko, O.. Universidad de Ginebra; Suiz

Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice

Idiopathic pulmonary fibrosis is a disease characterized by progressive, unrelenting lung scarring, with death from respiratory failure within 2–4 years unless lung transplantation is performed. New effective therapies are clearly needed. Fibroblast activation protein (FAP) is a cell surface-associated serine protease up-regulated in the lungs of patients with idiopathic pulmonary fibrosis as well as in wound healing and cancer. We postulate that FAP is not only a marker of disease but influences the development of pulmonary fibrosis after lung injury. In two different models of pulmonary fibrosis, intratracheal bleomycin instillation and thoracic irradiation, we find increased mortality and increased lung fibrosis in FAP-deficient mice compared with wild-type mice. Lung extracellular matrix analysis reveals accumulation of intermediate-sized collagen fragments in FAP-deficient mouse lungs, consistent with in vitro studies showing that FAP mediates ordered proteolytic processing of matrix metalloproteinase (MMP)-derived collagen cleavage products. FAP-mediated collagen processing leads to increased collagen internalization without altering expression of the endocytic collagen receptor, Endo180. Pharmacologic FAP inhibition decreases collagen internalization as expected. Conversely, restoration of FAP expression in the lungs of FAP-deficient mice decreases lung hydroxyproline content after intratracheal bleomycin to levels comparable with that of wild-type controls. Our findings indicate that FAP participates directly, in concert with MMPs, in collagen catabolism and clearance and is an important factor in resolving scar after injury and restoring lung homeostasis. Our study identifies FAP as a novel endogenous regulator of fibrosis and is the first to show FAP's protective effects in the lung